Journal
FOOD & FUNCTION
Volume 9, Issue 12, Pages 6415-6427Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8fo00964c
Keywords
-
Funding
- National Science and Technology Major Projects of New Drugs [2018ZX09301032, 2018ZX09733001-001-008]
- Strategic Priority Research Program of Chinese Academy of Sciences [XDA12040215]
Ask authors/readers for more resources
Parkinson's disease (PD) is a neurodegenerative disorder characterized by Lewy pathology and progressive loss of dopaminergic neurons in the substantia nigra. Lewy pathology mainly consists of abnormal aggregates of -synuclein, which play a pivotal role in PD pathophysiology. However, the complexity of PD leads to clinical challenges, and there are still no treatments to halt or slow the neurodegenerative process. Resveratrol (RV) is a natural polyphenol compound with multiple biological activities, which has been reported to exert neuroprotective effects on several neurological diseases. Here we first provided evidence that RV treatment alleviated motor and cognitive deficits in the A53T -synuclein mouse model of PD in a dose-dependent manner. The beneficial effects of RV against PD resulted from inhibiting -synuclein aggregation and cytotoxicity, lowering the levels of total -synuclein and oligomers, reducing neuroinflammation and oxidative stress. These findings suggest that RV has promising therapeutic potential for PD and other synucleinopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available